Scholar Rock Holding (SRRK) Total Non-Current Liabilities (2017 - 2021)

Scholar Rock Holding (SRRK) recorded quarterly Total Non-Current Liabilities of $115.4 million in Q2 2021, down 3.87% quarter-over-quarter from $120.0 million in Q1 2021.

Scholar Rock Holding (SRRK) Total Non-Current Liabilities (2017 - 2021) Analysis & Trends

Scholar Rock Holding's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $115.4 million for Q2 2021.

  • In Q2 2021, Total Non-Current Liabilities changed N/A year-over-year to $115.4 million; the TTM figure through Jun 2021 stood at $115.4 million (changed N/A YoY), while the FY2020 annual figure was $127.5 million, up 52.78% from the prior year.
  • Total Non-Current Liabilities was $115.4 million for Q2 2021 at Scholar Rock Holding, down from $120.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $127.5 million in Q4 2020 to a low of $5.9 million in Q4 2017.
  • Historically, Total Non-Current Liabilities has averaged $90.5 million across 4 years, with a median of $115.4 million in 2021.
  • Biggest YoY gain for Total Non-Current Liabilities was 52.78% in 2020; the steepest drop was 52.78% in 2020.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $5.9 million in 2017, then soared by 1317.16% to $83.5 million in 2019, then jumped by 52.78% to $127.5 million in 2020, then fell by 9.52% to $115.4 million in 2021.
  • The last three Total Non-Current Liabilities figures came in at $115.4 million (Q2 2021), $120.0 million (Q1 2021), and $127.5 million (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 115.39 Mn
Mar 31, 2021 120.04 Mn
Dec 31, 2020 127.53 Mn
Dec 31, 2019 83.47 Mn
Dec 31, 2017 5.89 Mn